# Efficacy of Atorvastatin in Chronic Subdural Haematoma

> **NCT03956368** · PHASE3 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 690 (estimated)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **DRUG:** Atorvastatin 20mg
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03956368
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-09
- **Primary completion:** 2022-09-16
- **Final completion:** 2023-03-16
- **Target enrollment:** 690 (ESTIMATED)
- **Last updated:** 2021-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03956368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03956368, "Efficacy of Atorvastatin in Chronic Subdural Haematoma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03956368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*